Intravenous self-administration of entactogen-class stimulants in male rats
about
Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsSex differences in abuse-related neurochemical and behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Clinical Pharmacology of the Synthetic Cathinone Mephedrone.Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerabilityCocaine-like discriminative stimulus effects of alpha-pyrrolidinovalerophenone, methcathinone and their 3,4-methylenedioxy or 4-methyl analogs in rhesus monkeys.High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration.Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (Methylone), and Caffeine in Rats.Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats."Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions.
P2860
Q33566201-AA51AE6B-8849-42BA-9D82-0A5638D46381Q34678483-C0D263BC-5E68-4B48-8138-B106304C6F1AQ36056252-1AE1A2CC-8ADB-419B-B7FC-35DEF7369CA8Q38840376-DF418529-A6D3-4D3C-8B87-A3D6F622B9E6Q39026719-B35CA450-D4AB-4D25-8D28-47709D90878EQ39052269-C2EE0188-B00E-45B2-BC5B-6118FCBC6115Q41640386-3C1AB2F0-420E-490C-B27C-998B99512224Q45031228-FED73565-E1DF-444E-82AE-2C5DEFAD157EQ47312691-3196D185-AE6F-4792-8951-508E15094C53Q47647717-DD8B688B-CDF1-48A2-B5A0-F8040A62CAFFQ47836720-1310D0D1-DFFF-4346-815D-81C92845E846Q48459385-BDB9C450-C044-4FE7-8D6A-BFA8187B55FAQ49602724-50F42071-A138-4D4B-9319-1EA3D7DAF0D0Q52309172-90281C6B-B937-4D14-A916-1DE4CDDB388F
P2860
Intravenous self-administration of entactogen-class stimulants in male rats
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Intravenous self-administration of entactogen-class stimulants in male rats
@ast
Intravenous self-administration of entactogen-class stimulants in male rats
@en
type
label
Intravenous self-administration of entactogen-class stimulants in male rats
@ast
Intravenous self-administration of entactogen-class stimulants in male rats
@en
prefLabel
Intravenous self-administration of entactogen-class stimulants in male rats
@ast
Intravenous self-administration of entactogen-class stimulants in male rats
@en
P2860
P1433
P1476
Intravenous self-administration of entactogen-class stimulants in male rats
@en
P2093
Kevin M Creehan
Sophia A Vandewater
P2860
P304
P356
10.1016/J.NEUROPHARM.2015.08.030
P577
2015-08-21T00:00:00Z